Daily non-political popular news in brief.

Drug industry spends nearly twice as much on marketing than on research and development

01-02-2008 · EurekAlert!

The pharmaceutical industry spends almost twice as much on the marketing and promotion of drugs than on research and development, according to a new analysis in this week's PLoS Medicine.

Keywords: drug, industry, spends, nearly, twice, marketing, research, development, spend

« Previous | Next »

Similar news on "Drug industry spends nearly twice as much on marketing than on research and development":

Study: Fountain of youth for your heart?
11-02-2007 · EurekAlert!
University of Alberta professor Jason Dyck's findings suggest that the protein responsible for transporting fat into the contractile cells of the heart may be a candidate for drug inhibition and that this drug could protect the heart from aging. This research holds great promise for human beings. Dyck hopes it will lead to the development of medications that inhibit the uptake of fatty acids into the heart and prevent and/or reverse the effects of aging on the heart muscle.
Similar news · Read more »
Study finds flaws in cancer clinical trials
02-01-2007 · EurekAlert!
Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center. That could explain why so many experimental drugs fail in the final large and costly phase of testing, they say.
Similar news · Read more »
Scripps research scientists find new genetic mutation that halts the development of lupus
01-17-2008 · EurekAlert!
Scientists at the Scripps Research Institute have uncovered a specific genetic mutation that suppresses the development of systemic lupus, an incurable autoimmune disease that causes the body to attack itself. The research suggests potential targets for future drug development.
Similar news · Read more »
Pain control after surgery reduces days of hospitalization
03-26-2007 · EurekAlert!
Effective postoperative pain control using continuous peripheral nerve block reduced hospitalization by nearly a day, University of Pittsburgh physicians reported today during the 81st Clinical and Scientific Congress of the International Anesthesia Research Society.Being able to decrease the time that patients spend in the hospital helps to reduce the patient’s exposure to the risk of hospital-acquired infection and associated complications, and also has an overall economic benefit, Dr. Chelly and his colleagues found.
Similar news · Read more »
Research finds link between depression
12-08-2007 · EurekAlert!
Depression nearly triples the risk of death following a heart attack, even when accounting for other heart attack risk factors, according to research presented today at the American College of Neuropsychopharmacology annual meeting, which showed that among 360 depressed, post myocardial infarction patients followed for more than six years, those who did not recover from their depression in the first six months were more than twice as likely to die.
Similar news · Read more »
Research links 'ecstasy' to survival of key movement-related cells in brain
10-18-2006 · EurekAlert!
New research from the University of Cincinnati suggests that the widely abused club drug "ecstasy," or MDMA, can increase the survival of dopamine cells in the brain during fetal development. Because these cells are critical in the regulation of voluntary movement, the findings, the researchers say, may lead to better therapies for neurological diseases like Parkinson's.
Similar news · Read more »
New forecasting tool could reduce drug development costs
02-01-2007 · EurekAlert!
It now costs more than $800 million to develop a new drug. But what if pharmaceutical companies could predict which experimental drugs will ultimately get FDA approval, and which will ultimately fail? Researchers present a forecasting model that could potentially save hundreds of millions of dollars per new drug. They also urge more data sharing by the drug industry to improve the accuracy of forecasting, allowing more medical discoveries to be brought to the bedside.
Similar news · Read more »
Skin-care industry skipping out on science?
08-22-2007 · EurekAlert!
The multibillion dollar global cosmetics and skin-care product industry sometimes is beset by a me-too mindset in which research and development focuses on matching the competition rather than applying sound science to improve products, a scientist who studies cosmetic ingredients said. As a result, it could be missing a golden opportunity to provide consumers with more effective products, he said. The study will be presented in August at the American Chemical Society national meeting in Boston.
Similar news · Read more »
Drug industry increasingly influences breast cancer research
02-26-2007 · EurekAlert!
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Similar news · Read more »
UWM brain research supports drug development from jellyfish protein
10-27-2006 · EurekAlert!
With the research support from the University of Wisconsin-Milwaukee, a Wisconsin biotech company has found that a compound from a protein found in jellyfish is neuroprotective and may be effective in treating neurodegenerative diseases.
Similar news · Read more »